Arg217

Site Information
YDrPGAGrGYNSIGr SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 9480287

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 , 5 , 6 )
Relevant cell line - cell type - tissue:	MEF (fibroblast) ( 1 , 2 , 3 , 4 , 5 , 6 )

References
1	Zhou J (2009) CST Curation Set: 6540; Year: 2009; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR Curated Info
2	Zhou J (2009) CST Curation Set: 6539; Year: 2009; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR Curated Info
3	Zhou J (2009) CST Curation Set: 6534; Year: 2009; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR Curated Info
4	Zhou J (2009) CST Curation Set: 6020; Year: 2009; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR Curated Info
5	Zhou J (2009) CST Curation Set: 6017; Year: 2009; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR Curated Info
6	Zhou J (2009) CST Curation Set: 6024; Year: 2009; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR Curated Info